1. Home
  2. VSTS vs CRMD Comparison

VSTS vs CRMD Comparison

Compare VSTS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$6.80

Market Cap

996.9M

Sector

N/A

ML Signal

HOLD

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$6.82

Market Cap

958.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
CRMD
Founded
1936
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.9M
958.1M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
VSTS
CRMD
Price
$6.80
$6.82
Analyst Decision
Sell
Strong Buy
Analyst Count
4
7
Target Price
$5.70
$17.29
AVG Volume (30 Days)
2.2M
4.1M
Earning Date
02-04-2026
11-12-2025
Dividend Yield
0.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.25
Revenue
$2,734,839,000.00
$214,303,672.00
Revenue This Year
N/A
$628.67
Revenue Next Year
$1.88
$14.64
P/E Ratio
N/A
$3.01
Revenue Growth
N/A
1647.67
52 Week Low
$3.98
$5.60
52 Week High
$16.56
$17.43

Technical Indicators

Market Signals
Indicator
VSTS
CRMD
Relative Strength Index (RSI) 54.66 22.73
Support Level $6.03 $7.01
Resistance Level $6.55 $7.44
Average True Range (ATR) 0.34 0.66
MACD -0.02 -0.53
Stochastic Oscillator 73.85 0.40

Price Performance

Historical Comparison
VSTS
CRMD

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: